An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjects - Phillips, J Theodore; Fox, Edward; Grainger, William; Tuccillo, Dianne; Liu, Shifang; Deykin, Aaron (BMC neurology, 2011)
Keywords: Adjuvants, Immunologic - administration & dosage; Adjuvants, Immunologic - adverse effects; Adjuvants, Immunologic - therapeutic use; Adult; Aged; Anxiety; Automation; Biomarkers, Pharmacological - blood; Demyelinating diseases; Design; Fear & phobias; Female; Humans; Injections, Intramuscular - instrumentation; Injections, Intramuscular - psychology; Interferon beta-1a; Interferon-beta - administration & dosage; Interferon-beta - adverse effects; Interferon-beta - therapeutic use; Male; Medicine; Medicine & Public Health; Middle Aged; Multiple Sclerosis - blood; Multiple Sclerosis - drug therapy; Multiple Sclerosis - psychology; Neopterin - blood; Neurochemistry; Neurology; Neurosciences; Neurosurgery; Pain; Patient Acceptance of Health Care - psychology; Patient Acceptance of Health Care - statistics & numerical data; Patient Preference - statistics & numerical data; Research Article; Self Administration - methods; Self Administration - psychology; Self Administration - statistics & numerical data; Syringes; Multiple Sclerosis; Avonex; Final Injection; Injection Process; Multiple Sclerosis Patient